The Nutshell

» funding, genetics & genomics and cancer

Daily News Roundup

Most Recent

image: Additional #IceBucketChallenge Payoffs

Additional #IceBucketChallenge Payoffs

By | July 28, 2016

Researchers identify a new ALS-associated gene thanks to funds generated by the social media challenge that went viral in summer 2014.

0 Comments

image: CRISPR Therapy to Enter Trials

CRISPR Therapy to Enter Trials

By | July 25, 2016

Researchers in China will use the CRISPR-Cas9 system to edit T cells extracted from patients with cancer before those cells are returned to the body to target malignant ones.

0 Comments

image: Distinguishing Circulating Tumor from Normal Cell-Free DNA

Distinguishing Circulating Tumor from Normal Cell-Free DNA

By | July 19, 2016

Fragments of circulating DNA from tumors are around 20 to 30 base pairs shorter than those from healthy cells, researchers report.

0 Comments

image: 23andMe Markets Genome Kits to Researchers

23andMe Markets Genome Kits to Researchers

By | July 14, 2016

Scientists can now buy the direct-to-consumer sequencing product, and research participants can join 23andMe’s database.

0 Comments

image: Open Letter Leads to Peer Review Changes

Open Letter Leads to Peer Review Changes

By | July 14, 2016

The Canadian Institutes of Health Research will reverse some of the recent changes to its grant-reviewing processes after protests from researchers.

0 Comments

image: Considering Gene Editing

Considering Gene Editing

By | July 12, 2016

An international committee continues its investigation into the ethical and social considerations of precision DNA editing technology with a public meeting held this morning in Washington, DC.

0 Comments

Juno Therapeutics asks the US Food and Drug Administration for permission to restart the CAR-T experiments without chemotherapy.

0 Comments

Nearly 1,200 scientists are asking the Canadian Institutes of Health Research to undo recent changes to its grant-review process.

0 Comments

image: CRISPR Combats Herpes

CRISPR Combats Herpes

By | July 5, 2016

Scientists use the gene editing technology to target active and latent virus in mammalian cell cultures.

0 Comments

Human cancer cells constrained to capillary-like microtubes divide unevenly, scientists show.

0 Comments

Popular Now

  1. Broad Wins CRISPR Patent Interference Case
    Daily News Broad Wins CRISPR Patent Interference Case

    The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.

  2. Cannibalism: Not That Weird
    Reading Frames Cannibalism: Not That Weird

    Eating members of your own species might turn the stomach of the average human, but some animal species make a habit of dining on their own.

  3. Henrietta Lacks’s Family Seeks Compensation
  4. Can Plants Learn to Associate Stimuli with Reward?
Business Birmingham